EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RB1, development, and cancer



RB1, development, and cancer



Current Topics in Developmental Biology 94: 129-169



The RB1 gene is the first tumor suppressor gene identified whose mutational inactivation is the cause of a human cancer, the pediatric cancer retinoblastoma. The 25 years of research since its discovery has not only illuminated a general role for RB1 in human cancer, but also its critical importance in normal development. Understanding the molecular function of the RB1 encoded protein, pRb, is a long-standing goal that promises to inform our understanding of cancer, its relationship to normal development, and possible therapeutic strategies to combat this disease. Achieving this goal has been difficult, complicated by the complexity of pRb and related proteins. The goal of this review is to explore the hypothesis that, at its core, the molecular function of pRb is to dynamically regulate the location-specific assembly or disassembly of protein complexes on the DNA in response to the output of various signaling pathways. These protein complexes participate in a variety of molecular processes relevant to DNA including gene transcription, DNA replication, DNA repair, and mitosis. Through regulation of these processes, RB1 plays a uniquely prominent role in normal development and cancer.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333565

Download citation: RISBibTeXText

PMID: 21295686

DOI: 10.1016/B978-0-12-380916-2.00005-X



Related references

Development of a novel nanocarrier focusing on the physicochemical properties of an anti-cancer therapy drug--development of anti-cancer nanoparticles containing vitamin E derivative with mulitifaceted anti-cancer effect. Yakugaku Zasshi 134(10): 1049-1054, 2015

Development of colorectal cancer in ulcerative colitis, clinicopathological study of 347 patients and new concepts of cancer development from analysis of mucosal cell proliferation activity. Stomach & Intestine 28(2): 171-179, 1993

The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets. Seminars in Oncology 43(1): 189-197, 2016

Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16). Value in Health 15(1): 183-190, 2012

Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio. Journal of Urology 171(2 Pt 2): S68-74; Discussion S75, 2004

Improving cancer patient care: development of a generic cancer consumer quality index questionnaire for cancer patients. Bmc Cancer 13: 203-203, 2014

Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute. Journal of Cellular Biochemistry. Supplement 20: 55-62, 1994

Role of the National Cancer Institute in the development of cancer centers. VI. Review and evaluation of cancer research center grant applications. Cancer 29(4): 896-901, 1972

Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine. Current Molecular Medicine 11(7): 564-581, 2012

Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Research 5(2): 101-106, 2003

A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of International Criteria for the Determination of Microsatellite Instability in Colorectal Cancer. Cancer Res., 58: 5248-5257, 1998 (and reply). Cancer Research 59(1): 249-256, 1999

A label free Ag+ sensing method via in situ formation of metal coordination polymer. Analytical Biochemistry, 2018

Development of the novel anti-cancer immunotherapy for human prostate cancer In vivo characterization of an immunotropic and anti-cancer activities of the new polysaccharide from the leaves of Panax ginseng CA Meyer. European Urology Supplements 3(2): 94, February, 2004

Expression of ADAMTS12 in colorectal cancer-associated stroma prevents cancer development and is a good prognostic indicator of colorectal cancer. Digestive Diseases and Sciences 56(11): 3281-3287, 2011

Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Research 11(5): 209-209, 2010